6 Geographic Atrophy Clinical Trials in Bakersfield, CA (2026)

Q: How do I join a clinical trial in Bakersfield?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bakersfield research site will contact you.

Recruiting Geographic Atrophy Studies in Bakersfield

NCT06901531Recruiting

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesophageal junction (GEJ) cancer. Zolbetuximab with che...

Bakersfield, CAPHASE3500 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT06659445Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

The purpose of this study is to collect efficacy and safety information of intravitreal injection for 3 experimental arms, including 2 dose levels of ONL1204 and 2 treatment frequencies in patients wi...

Bakersfield, CAPHASE2324 participantsONL Therapeutics

View Study Details

NCT07606365Recruiting

A Study in Adults With Geographic Atrophy

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD)....

Bakersfield, CAPHASE2300 participantsSitala Bio LTD

View Study Details

NCT06990269Recruiting

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Phase 2 study is designed to assess the efficacy of ADX-038 compared with placebo in participants with GA secondary to AMD. Safety, pharmacokinetics (PK), and pharmacodynamics (PD) will also be assess...

Bakersfield, CAPHASE2240 participantsADARx Pharmaceuticals, Inc.

View Study Details

NCT07215390Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

A Phase 2, Randomized, Placebo-controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL-3007 in Combination with Syfovre/Pegcetacopla...

Bakersfield, CAPHASE2240 participantsApellis Pharmaceuticals, Inc.

View Study Details

NCT07439887Recruiting

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

A Phase 1/2, open-label, non-randomized, dose-escalation study, where a minimum of 9 and a maximum of 18 eligible patients with Stargardt Disease will be enrolled sequentially in up to 3 dose cohorts ...

Bakersfield, CAPHASE118 participantsRay Therapeutics, Inc.

View Study Details

About Geographic Atrophy Clinical Trials in Bakersfield

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 6 geographic atrophy clinical trials recruiting participants in Bakersfield, CA. These studies are seeking a combined 1,622 participants. Research is being sponsored by Astellas Pharma Global Development, Inc., ONL Therapeutics, Sitala Bio LTD and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Bakersfield — FAQ

Are there geographic atrophy clinical trials in Bakersfield?

Yes, there are 6 geographic atrophy clinical trials currently recruiting in Bakersfield, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bakersfield?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bakersfield research site will contact you about next steps.

Are clinical trials in Bakersfield free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bakersfield studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 6 active trials in Bakersfield are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 15, 2026 from ClinicalTrials.gov